Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility

02/03/2017

PTCOMMUNITY

Sanofi and Lonza announced that they have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland. The strategic partnership in the form of a joint venture combines the strong biologics development pipeline of Sanofi with the expertise of Lonza to design, construct, start-up and operate a state-of-the-art large-scale mammalian cell culture facility.

 

Click here to read full article